Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Champagne Flows As CTLA-4/PD-1 Pioneers Allison And Honjo Win Nobel Prize

Executive Summary

Joint prize for MD Anderson's James Allison and Kyoto University's Tasuku Honjo for checkpoint immunotherapy reflects decades of research and billions of IO dollars for industry.

Advertisement

Related Content

Sanofi/Regeneron's IO Springboard Libtayo Cleared For Skin Cancer
First-Line Chemo Combo Data Help Merck's Keytruda Power Past Opdivo
BIO Notebook Day 1: Other Therapeutic Areas Left Behind As Deal-Making, Financing Focus On Oncology, Rare Diseases
Bristol/Medarex: A Transformational Acquisition Rooted In Collaboration
Oncology Disruption Demands Strategic Transformation
Bristol's CheckMate 067 Revives Debate On Rationing Yervoy/Opdivo Combo
MD Anderson Helps Pfizer, J&J Play Catch-up In Cancer Immunotherapy
Melanoma Success Paves Way For Path Of Gold In Cancer Immunotherapy
Yervoy Cuts To The Head Of The Line: Ipilimumab Has Unrestricted Label
Ipilimumab Data Impress, But Vaccine Control Could Complicate Review

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC123929

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel